切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2010, Vol. 06 ›› Issue (02) : 146 -149. doi: 10.3877/cma.j.issn.1673-5250.2010.02.024

综述

小于胎龄儿与生长激素治疗
崔继华   
  1. 610041 成都,四川大学华西第二医院儿童保健科
  • 出版日期:2010-04-01

Small for Gestational Age and Growth Hormone Treatment

Ji-hua CUI   

  1. Department of Neonates, West China Second University Hospital, Sichuan University, Chengdu 610041, China
  • Published:2010-04-01
引用本文:

崔继华. 小于胎龄儿与生长激素治疗[J/OL]. 中华妇幼临床医学杂志(电子版), 2010, 06(02): 146-149.

Ji-hua CUI. Small for Gestational Age and Growth Hormone Treatment[J/OL]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2010, 06(02): 146-149.

小于胎龄(small for gestational age,SGA)儿是指出生时体重指数为适于胎龄(appropriate for gestational age,AGA)儿平均体重的第10百分位以下,或低于适于胎龄儿平均体重2个标准差(s)的新生儿,其成年后易出现身材矮小。近年来,生长激素(growth hormone,GH)用于治疗小于胎龄儿取得较好效果,本文对此综述如下。

Small for gestational age (SGA)children were de? ned as birth weight or length or ponderal index>2 s scores below the respective mean for the gestational age and sex, which were at risk of long-term growth deficits. Small for gestational age children maintained a small body size throughout childhood and often into adult life. In recent years, the potential benefits of growth hormone(GH) treatment, resulting in a significant height gain in children born small for gestational age, had been well documented.

1 Lelbach A, Muzes G, Feher J. The insulin - like growth factor system:IGFs, IGF-binding proteins and IGFBP - proteases[J].Acta Physiol Hung,2005,92(2):97-107.
2 Verhaeghe J, Van Bree R, Van Herck E,et al. C-peptide, insulin-like growth factors-Ⅰ and Ⅱ,insulin-like growth factor binding protein-Ⅰ inumbilical cord serum: Correlations with birth weight[J].Am J Obstet Gynecol, 1993, 169(1):89- 97.
3 Rank MB,Lindberg A,Cowell CT,et al.Prediction of response to growth hormone treatment in short children born small for gestational age: Analysis of data feom KIGS(Pharmacia international growth database)[J].J Clin Endocrinol Metab,2003,88(1):125-131.
4 Moore SE,Falorni A,Bini V,et al.Ethnic differences in the relationship between fasting leptin and BMI in children[J]. Int J Obes Relat Metab Disord,2004,28(1):17-21.
5 Onal EE, Cinaz P, Atalay Y, et al. Umbilical cord ghrelin concentrations in small-and appropriate-for-gestational age newborn infants : Relationship to anthropometric markers[J].J Endocrinol, 2004,180:267-271.
6 Farquhar J, Heiman M,Alfred CK, et al. Elevated umbilical cord ghrelin concentrations in small for gestational age neonates[J].J Clin Endocrinol Metab, 2003,88(9):4324-4327.
7 Kitamura S, Yokota I, Hosoda H, et al. Ghrelin concentration incord and neonatal blood: Relation to fetal growth and energy balance [J].J Clin Endocrinol Metab, 2003,88(11):5473- 5477.
8 Liora L, Pollak1 U, Kalter-Leibovici O, et al. Pubertal course of persistently short children born small for gestational age (SGA) compared with idiopathic short children born appropriate for gestational age (AGA) [J].Eur J Endocrinol,2003, 149:425-432.
9 Trivin C, Souberbielle JC,Aubertin G, et al. Diagnosis of idiopathic growth hormone deficiency: Contributions of data on the A cidlabile subunit,insulin-like growth factor (IGF)-1, and IGF-1, and IGFBP-3[J]. J Pediatr Endocrinol Metab,2006,19(4):481-489.
10 Clayton PE, Cianfarani S, Czernichow P,et al. Management of the child born small for gestational age child(SGA) through to adulthood: A consensus statement of the international societies of paediatric endocrinology and the growth hormone research society[J]. J Clin Endocrinol Metab,2007,92(3):804-810.
11 Enie B, Yvonne VP, Paul M, et al. Puberty in growth hormone-treated children born small for gestational age (SGA) [J].J Clin Endocrinol Metab,2003,88:5753-5758.
12 Lagrou K, Vanderfaeillie J, Froidecoeur C,et al. Effect of 2 years of high-dose growth hormone therapy on cognitive and psychosocial development in short children born small for gestational age[J]. Eur J Endocrinol,2007,156(2):195-201.
13 Hokken Koelega A,Van Pareren Y, Nicolette A. Effects of growth hormonetreatment on cognitive function and head circumference in children born small for gestational age[J]. Horm Res, 2005,64(suppl 3) :S95-S99.
14 Gunnell D, Miller LL, Rogers I, et al. Association of insulin-like growth factor Ⅰ and insulin-like growth factor -binding protein-3 with intelligence quotient among 8-to 9-year-old children in the avon longitudinal study of parents and children[J]. Pediatrics, 2005, 116:681-686.
15 Travaglino P, Buzi F,Meazza C, et al. Response to long - term growth hormone therapy in short children with reduced GH bioactivity[J]. Horm Res, 2006,66(4):189-194.
16 Cutfield WS, Lindberg A, Rapaport R, et al. Safety of growth hormone treatment in children born small for gestational age: The US trial and KIGS analysis[J]. Horm Res, 2006, 65(suppl3):S153-S159.
17 Lee PA,Chernausek SD, Hokken-Koelega AC, et al. International small for gestational advisory board consensus development conference statement management of short children born small for gestational age, April 24-October 1, 2001[J]. Pediatrics, 2003, 111(6):1253-1261.
18 Marijevan D, Ellen MN, Bannink, YK, et al.Risk factors for diabetes mellitus type 2 and metabolic syndrome are comparable for previously growth hormone-treated young adults born small for gestational age (SGA) and untreated short SGA controls[J]. J Clin Endocrinol Metab,2007,92(1):160-165.
19 Ibanez L,Fucci A, Valls C, et al. Neutrophil count in small-for-gestational age children:Contrasting effects of metformin and growth hormone therapy[J].J Clin Endocrinol Metab, 2005,90:3435-3439.
20 Castro AM, Guerra-Junior G.GH/IGF-1 and cancer: What's new in this association.[article in Portuguese] [J].Arq Bras Endocrinol Metab,2005,49(5):833-842.
21 Eyal O, Naffaa LN, Elder DA. A case of macroprolactinoma and elevatedinsulin-like growth factor-1 in a young boy [J]. Acta Paediatr,2005,94(12): 1852-1854.
[1] 李倩, 刘倩, 朱海玲, 倪娟, 任宝芹, 刘长云. 重组人生长激素治疗特发性矮小症患儿的疗效[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(03): 346-352.
[2] 张雪灵, 陈玮彬, 魏雯硕, 陈明, 诸宏伟. 努南综合征的临床特点与治疗效果分析[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(02): 192-199.
[3] 冉晨曦, 沈如飞, 廖明钰, 廖倩, 周玲, 张玉玲, 隆敏. 垂体瘤孕妇的诊治与围分娩期管理[J/OL]. 中华妇幼临床医学杂志(电子版), 2023, 19(04): 487-491.
[4] 许可, 宁刚. 基于人工智能的骨龄辅助评价系统对四川地区完全性生长激素缺乏症患儿骨龄研究[J/OL]. 中华妇幼临床医学杂志(电子版), 2022, 18(04): 449-459.
[5] 王淼, 宋小宇, 高宇, 李学超. 不同剂量重组人生长激素治疗儿童中枢性性早熟的临床效果[J/OL]. 中华妇幼临床医学杂志(电子版), 2019, 15(04): 437-443.
[6] 陈丽娜, 向承发. 重组人生长激素对身材矮小的小于胎龄儿身高的促增长作用[J/OL]. 中华妇幼临床医学杂志(电子版), 2012, 08(05): 585-587.
[7] 许彬东, 黄国忠, 谢金标, 赵金树, 陈豪, 陈思曾. 生长激素强化的肠外营养支持对老年食管癌患者术后机体营养及免疫功能的影响[J/OL]. 中华普通外科学文献(电子版), 2013, 07(05): 358-362.
[8] 钟昭众, 熊志勇, 梁豪, 袁峰, 曹明波, 向莎, 邓美海. 生长激素受体与肝细胞癌增殖迁移及预后的关系[J/OL]. 中华肝脏外科手术学电子杂志, 2021, 10(02): 210-214.
[9] 万晶晶, 徐东升, 杨丙寅, 马兴刚. 重组人生长激素治疗溃疡性结肠炎临床对照研究[J/OL]. 中华结直肠疾病电子杂志, 2016, 05(06): 480-483.
[10] 田沁涛, 黑悦, 伊西才, 魏礼洲, 王博晨, 刘卫平. RET的表达与生长激素型垂体腺瘤患者生长激素水平的相关性分析[J/OL]. 中华神经创伤外科电子杂志, 2016, 02(04): 198-201.
[11] 苏杭, 仇尔宁, 容耔耘. 生长激素联合肠内营养改善重症颅脑损伤后昏迷患者营养状态及临床预后的研究[J/OL]. 中华脑科疾病与康复杂志(电子版), 2019, 09(03): 150-153.
[12] 李彩梅, 丁晓春. 小于胎龄儿出生后血清维生素B12及脑发育水平研究[J/OL]. 中华临床医师杂志(电子版), 2020, 14(05): 370-375.
[13] 李艳英, 张梅, 王少春, 刘丹丹, 晏文华, 班博. 儿童生长激素缺乏症患者血清血脂水平与心外膜脂肪厚度的相关性研究[J/OL]. 中华诊断学电子杂志, 2018, 06(01): 48-52.
[14] 孙海玲, 班博, 潘慧, 朱慧娟, 张梅, 李萍. 生长激素激发试验在矮小儿童临床诊断中的价值[J/OL]. 中华诊断学电子杂志, 2014, 02(02): 105-108.
[15] 林懋全, 王存川, 杨景哥, 张艺超. LRYGB 和LSG 治疗T2DM 的疗效及对GLP-1 和Ghrelin 水平的影响[J/OL]. 中华肥胖与代谢病电子杂志, 2015, 01(02): 80-84.
阅读次数
全文


摘要